BioSpace News Archive

Factor Bioscience Inc., a Cambridge-based biotechnology company focused on developing therapeutic cell-engineering technologies, today announced that the United States Patent and Trademark Office has granted Factor Bioscience U.S. Patent No. 10,662,410 covering methods for producing a gene-edited cell using mRNA encoding transcription activator-like effector nucleases (TALENs)

Pendulum Therapeutics, an evidence-based microbiome company, is proud to announce that CEO and Co-Founder Colleen Cutcliffe, Ph.D., has accepted an invitation to join the Leadership Board of the American Diabetes Association, Northern California chapter.

New England Biolabs (NEB®) has announced its pledge of $100,000 to the Vaccine and Immunotherapy Center (VIC) at Mass General Hospital (MGH).

Frontage Laboratories, a contract research organization (“CRO”) providing integrated, science-driven, product development services, has established a Quantitative Whole‑Body Autoradiography (QWBA) Center of Excellence (COE) at our Exton PA facility.

Oncopeptides AB ‘s Annual General Meeting 2020 was held , at Tändstickspalatset in Stockholm.

Tauriga Sciences Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with proprietary CBD & CBG infused chewing gums and edibles product(s) as well as two ongoing Biotechnology initiatives, today announced the arrival of Peach-Lemon flavor Cannabigerol (“CBG”) infused Tauri-Gum™ inventory – at its E-Commerce fulfillment center.

Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, today announced that management will present at the June 2020 Virtual Investor Summit on June 9-12, 2020. Marrone Bio Innovations management will host virtual one-on-one investor meetings throughout the event and is scheduled to present as follows: Virtual Investor Summit Date: Tuesday, June 9,

Sharps Compliance Corp. announced that David P. Tusa, Chief Executive Officer will be presenting at the Stifel 2020 Virtual Cross Sector Conference on June 9, 2020 at 9:20 a.m. Eastern time.

Beyond Air, Inc. announced that Health Canada approved the use of the LungFit™ system for a study in hospitalized patients diagnosed with COVID-19 caused by the severe acute respiratory syndrome coronavirus 2.

Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical stage company developing treatments for rare and specialty diseases with significant unmet needs, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Intravenous (IV) Choline Chloride for the treatment of intestinal failure-associated liver disease (IFALD). IV Choline Chloride is the Company’s Phase 3-ready investigational phospholipid substrate re